Research Groups and Labs
Research is supported by more than $29 million in annual extramural funding in eight departments and four divisions in the School of Medicine, including global health initiatives supported by the Bill & Melinda Gates Foundation and the NIH, and carried out with partners in countries around the world, among them Bangladesh, Brazil, Haiti, South Africa, Tanzania, and Uganda.
Scott Heysell, MD, MPH
Thomas H. Hunter Associate Professor of International Medicine
The research group focuses on optimizing technologies and gaining a better understanding of anti-tuberculosis (TB) drug pharmacokinetics and pharmacodynamics to improve treatment outcomes in patients with mycobacterial diseases or with comorbid HIV, diabetes, and/or malnutrition. Consequent secondary areas of interest include the development of laboratory assays for pharmacokinetic and pharmacodynamic studies, the building of infrastructure for community-based research in TB-endemic settings, clinical trials of TB drug regimens, machine learning analyses for outcomes prediction, and health systems research for growing equity-based solutions to social drivers of health.
Eric Houpt, MD
The Houpt Group Laboratory—within the Division of Infectious Diseases & International Health—is involved in projects focused on molecular diagnostic tools for infectious diseases. We search for a research diagnostic that can rapidly and accurately identify acute febrile illness agents and develop panels of PCR-based diagnostic tests to detect a full range of enteropathogens.
We focus on tuberculosis research, trying to improve patient outcomes by developing rapid diagnostics that can identify which drugs to use and identifying markers for poor therapeutic response.
William A. Petri, Jr., MD, PhD
- Wade Hampton Frost Professor of Medicine and Vice Chair for Research, Department of Medicine
- Professor of Medicine – Microbiology, Immunology and Cancer Biology; Pathology; Medicine- Infectious Diseases and International Health
William A. Petri, Jr., M.D., Ph.D. studies immunology and molecular pathogenesis of infectious diseases and their consequences. The scope of the research includes immunopathogenesis and vaccine development for COVID-19, molecular parasitology of Entamoeba, innate immune host defense against Clostridium difficile, and in Bangladesh, acquired immunity to Cryptosporidium. We study infections in mouse models, in humans (including clinical trials), and at the lab bench.
Tania A. Thomas, MD MPH
Department of Medicine, Division of Infectious Diseases and International Health
Tuberculosis, childhood tuberculosis, biomarkers, HIV, HPV-related anal dysplasia